Pfizer Won't Face Retrial In Premarin Breast Cancer Suit
An Arkansas federal judge refused Wednesday to grant a new trial to a woman who claimed Premarin and other menopause hormone therapy drugs by Pfizer Inc. units Wyeth Pharmaceuticals Inc. and...To view the full article, register now.
Already a subscriber? Click here to view full article